Proliferation, DNA ploidy, p53 overexpression and nuclear DNA fragmentation in six equine melanocytic tumours.

The research article is about an in-depth examination of equine melanocytic tumours on the molecular level, focusing especially on their growth factors, p53 overexpression, and DNA characteristics, such as fragmentation and ploidy, to determine how horse melanomas differ from other species.

Research Study Details

• The research team investigated six equine melanocytic tumours from five horses. Of these, two were metastatic (cancer that has spread from its primary location) and the rest were benign (non-cancerous).
• Various staining techniques, such as Ki67, PCNA, p53, Tunel, and Feulgen staining, were employed to evaluate the tumours, with quantitative image analysis serving as the assessment method.
• These techniques allowed the researchers to analyze various parameters associated with the tumours’ activities. These parameters included the growth fraction, S-phase index (related to DNA replication), p53 index (the extent of p53 protein, which suppresses tumour growth), apoptotic index (the rate of cell death), DNA index, nuclear diameter, ploidy balance, proliferation index, and hyperploidy (having many copies of a chromosome in each cell).

Research Findings

• Overexpression of the p53 protein was observed in metastatic melanomas, along with apoptosis or programmed cell death. However, the researchers observed no differences in growth, S-phase index, and DNA configuration between metastatic and benign tumours.
• Contrary to expectations, there was no evidence of mutant p53 in the tumours, suggesting that this protein’s overexpression could be a response to other factors rather than its mutation.
• The researchers found variances in the phenotype characteristics of equine melanomas compared to those in dogs, cats, and humans, especially regarding the proliferative activity of benign tumours, indicating potentially different biological behaviours and mechanisms.

Conclusions

• The study concluded that the melanocytic tumours in horses demonstrate different phenotypic attributes compared with similar tumours in other species. The results also suggest that the prognostic markers applied for predicting the clinical behaviour of melanomas in other species do not appear to have the same value in horses.
• The study also found that neither quantitative DNA changes nor p53 mutations seem to be key factors in the development of these melanomas in horses.